Companies: 10,795·Total market cap: $144.5T
Urologix, Inc.

Urologix, Inc.

ULGXOTCHealthcare● Active
$0.00
+$0.00(+0.00%)
Market Cap$2182
P/E Ratio
52W High$0.0126
52W Low$0.0001
Overview

Urologix, Inc.(ULGX)· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · ULGX · 截至 2026-06-09

财务报表

Revenue · Gross Profit · Net Income
Breakdown2014-062013-062012-062011-062010-06
Revenue
Revenue$14.23M$16.59M$17.03M$12.57M$14.77M
Cost of Revenue$8.14M$8.41M$8.64M$6.03M$6.57M
Gross Profit$6.09M$8.18M$8.38M$6.54M$8.20M
Gross Margin %(computed)42.80%49.32%49.23%52.03%55.53%
Operating Expenses
R&D Expenses$1.63M$2.27M$2.19M$2.24M$1.83M
G&A Expenses$2.30M$2.52M$3.39M$0.00M$0.00M
Total Operating Expenses$10.09M$11.95M$12.53M$10.27M$10.46M
Operating Income($6.93M)($3.92M)($4.14M)($3.73M)($2.26M)
Operating Margin %(computed)-48.68%-23.64%-24.34%-29.64%-15.28%
Interest Income$0.00M$0.00M$0.00M$0.00M$0.00M
Interest Expense$0.69M$0.56M$0.48M$0.00M$0.00M
Income Before Tax($7.62M)($4.28M)($4.64M)($3.73M)($2.26M)
Income Tax Expense($0.02M)$0.01M$0.06M$0.01M($0.09M)
Net Income($7.61M)($4.29M)($4.70M)($3.73M)($2.17M)
Net Margin %(computed)-53.45%-25.87%-27.57%-29.70%-14.68%
Per Share & EBITDA
EPS (Basic)$-0.36$-0.21$-0.32$-0.26$-0.15
Wtd Avg Shares21.22M20.70M14.74M14.56M14.51M
EBITDA($6.34M)($3.05M)($3.46M)($3.16M)($1.46M)
EBITDA Margin %(computed)-44.57%-18.37%-20.34%-25.14%-9.91%

数据来源:Financial Modeling Prep · 最后更新:2026-06-09 · USD · M

深入了解Urologix, Inc.

关于Urologix, Inc.(ULGX)损益表

Urologix, Inc.(ULGX)损益表数据来源于SEC Form 10-K及10-Q申报文件。2014财年,ULGX实现营收$0.01B,毛利润$0.01B(毛利率42.80%),净利润($0.01B)(净利率-53.45%)。

常见问题

ULGX · 4 问

Urologix, Inc.(ULGX)2014财年营收为$0.01B,同比down14.2%。

ULGX revenueULGX salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09